EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Catheter Precision's enterprise value is $0.26 Mil.
Catheter Precision's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was $-14.70 Mil. Therefore, Catheter Precision's EV-to-EBITDA for today is -0.02.
The historical rank and industry rank for Catheter Precision's EV-to-EBITDA or its related term are showing as below:
VTAK'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -12.55 Med: 0.18 Max: 0.69
Current: -0.02
During the past 8 years, the highest EV-to-EBITDA of Catheter Precision was 0.69. The lowest was -12.55. And the median was 0.18.
VTAK's EV-to-EBITDA is ranked worse than 100% of 489
companies
in the Medical Devices & Instruments industry
Industry Median: 15.23
vs VTAK: -0.02
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-04-25), Catheter Precision's stock price is $0.575.
Catheter Precision's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-24.010. Therefore, Catheter Precision's PE Ratio for today is At Loss.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
Catheter Precision EV-to-EBITDA Historical Data
The historical data trend for Catheter Precision's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Catheter Precision's EV-to-EBITDA
For the Medical Devices subindustry, Catheter Precision's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Catheter Precision's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Catheter Precision's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Catheter Precision's EV-to-EBITDA falls into.
Catheter Precision EV-to-EBITDA Calculation
Catheter Precision's EV-to-EBITDA for today is calculated as:
Catheter Precision's current Enterprise Value is $0.26 Mil.
Catheter Precision's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-14.70 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Catheter Precision's PE Ratio for today is calculated as:
Catheter Precision's share price for today is $0.575.
Catheter Precision's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-24.010.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of Catheter Precision's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
Catheter Precision (Catheter Precision) Business Description
Catheter Precision Inc Formerly Ra Medical Systems Inc is a commercial-stage medical device company whose business comprises of the design, manufacture and sale of new medical technologies in the field of cardiac electrophysiology, or EP. Its product, View into Ventricular Onset System or VIVO System which is a non invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. . It operates business as one segment which includes all activities related to the marketing, sales and development of medical technologies in the field of cardiac EP.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VTAK has been successfully added to your 